Arriving in the landscape of obesity treatment, retatrutide presents a distinct method. Unlike many available medications, retatrutide operates as a dual agonist, concurrently engaging both GLP-like peptide-1 (GLP-1) and glucose-dependent peptides, retatrutide, glp, glp-2,glp-3, bpc-157, glutathione, tesamoreli insulinotropic polypeptide (GIP) bind